Spots Global Cancer Trial Database for soft tissue
Every month we try and update this database with for soft tissue cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Bevacizumab/Doxorubicin/Radiation for Sarcoma | NCT01746238 | Sarcoma | Bevacizumab Doxorubicin Radiation Thera... | 18 Years - | Massachusetts General Hospital | |
| Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities | NCT04220229 | Sarcoma of the ... Stage I Soft Ti... Stage IA Soft T... Stage IB Soft T... Stage II Soft T... | Cabozantinib S-... Radiation Thera... | 18 Years - | University of Washington | |
| Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas | NCT01048723 | Sarcoma | RAD001 | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study in Localized and Disseminated Ewing Sarcoma | NCT00987636 | Ewing's Sarcoma | Zoledronic acid Busulfan Treosulfan | 48 Months - 50 Years | University Hospital Muenster | |
| Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities | NCT04220229 | Sarcoma of the ... Stage I Soft Ti... Stage IA Soft T... Stage IB Soft T... Stage II Soft T... | Cabozantinib S-... Radiation Thera... | 18 Years - | University of Washington | |
| Application of Magnetic Resonance Fat-Free Imaging | NCT00944476 | Sarcoma | Fat-free MRI im... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors | NCT00722293 | Neoplasms, Brea... | Doxorubicin Pazopanib (GW78... Epirubicin | 18 Years - | GlaxoSmithKline | |
| PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma | NCT01209598 | Sarcoma Liposarcoma | Palbociclib 200... Palbociclib 125... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Cytogenetic and Molecular Genetic Studies in Bone Sarcomas | NCT00579930 | Lung Cancer | - | Memorial Sloan Kettering Cancer Center | ||
| Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) | NCT01078415 | Carcinoma, Hepa... | Ablation with t... | 18 Years - | Angiodynamics, Inc. | |
| Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma | NCT00753727 | Soft Tissue Sar... | Sunitinib malat... Radiotherapy | 16 Years - | Australasian Sarcoma Study Group | |
| Study in Localized and Disseminated Ewing Sarcoma | NCT00987636 | Ewing's Sarcoma | Zoledronic acid Busulfan Treosulfan | 48 Months - 50 Years | University Hospital Muenster | |
| Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma | NCT02945800 | Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Soft Tissue Sar... | nab-Paclitaxel Gemcitabine | 3 Years - 30 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) | NCT04634227 | Sarcoma Soft Tissue Sar... Unresectable So... Metastatic Bone... Bone Sarcoma | Ascorbate | 18 Years - | University of Iowa | |
| Cytogenetic and Molecular Genetic Studies in Bone Sarcomas | NCT00579930 | Lung Cancer | - | Memorial Sloan Kettering Cancer Center | ||
| Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) | NCT01078415 | Carcinoma, Hepa... | Ablation with t... | 18 Years - | Angiodynamics, Inc. | |
| PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma | NCT01209598 | Sarcoma Liposarcoma | Palbociclib 200... Palbociclib 125... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes | NCT00887809 | Sarcoma Leiomyosarcoma Malignant Fibro... Histiocytoma Angiosarcoma | gemcitabine docetaxel bevacizumab | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma | NCT00870701 | Soft Tissue Sar... | Radiotherapy absence of radi... | 18 Years - | Institut Claudius Regaud | |
| A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors | NCT00722293 | Neoplasms, Brea... | Doxorubicin Pazopanib (GW78... Epirubicin | 18 Years - | GlaxoSmithKline | |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults | NCT03468075 | Sarcoma Soft Tissue Sar... Unresectable So... Metastatic Bone... Bone Sarcoma | Ascorbate Gemcitabine | 18 Years - | University of Iowa | |
| Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities | NCT04220229 | Sarcoma of the ... Stage I Soft Ti... Stage IA Soft T... Stage IB Soft T... Stage II Soft T... | Cabozantinib S-... Radiation Thera... | 18 Years - | University of Washington | |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults | NCT03468075 | Sarcoma Soft Tissue Sar... Unresectable So... Metastatic Bone... Bone Sarcoma | Ascorbate Gemcitabine | 18 Years - | University of Iowa | |
| High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas | NCT03508726 | Soft Tissue Sar... | Ascorbate | 18 Years - | University of Iowa | |
| Bevacizumab/Doxorubicin/Radiation for Sarcoma | NCT01746238 | Sarcoma | Bevacizumab Doxorubicin Radiation Thera... | 18 Years - | Massachusetts General Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
